Aditxt, Inc. (ADTX) vs Jaguar Animal Health, Inc. (JAGX)

Aditxt, Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. Aditxt, Inc. and Jaguar Animal Health, Inc. are of similar size ($4.4M and $4.2M). Aditxt, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −74.2%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −372,998.6%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 15 metrics below, Jaguar Animal Health, Inc. leads on 11 and Aditxt, Inc. on 4.

Valuation

Metric ADTX JAGX Biotechnology median
P/E n/m 0.00 8.58
P/S n/m 0.00 10.29
P/B n/m 0.02 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m 0.14 0.67
EV/Sales 73.26 (0.11) 9.89
Earnings yield 0.00% 82,577.65% (31.56%)
Free cash flow yield 0.00% (6,233.72%) (23.42%)

Profitability

Metric ADTX JAGX Biotechnology median
Gross margin 20.28% 82.31% 65.77%
Operating margin (128,143.36%) (93.10%) 0.00%
Net margin (372,998.60%) (188.46%) 0.00%
Free cash flow margin (129,979.72%) (24.03%) 0.00%
Return on equity 549.59% (1,125.38%) (54.09%)
Return on assets (236.38%) (127.14%) (47.78%)
Return on invested capital 0.00% (28,393.64%) 0.00%

Growth

Metric ADTX JAGX Biotechnology median
Revenue growth (TTM) (74.19%) 135.52% 5.83%
EPS growth (last fiscal year) (918.27%) 82.42% 29.36%
Revenue growth, 5-year CAGR — 4.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX JAGX Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 0.06 0.69 4.80
Net debt to EBITDA 0.18 (0.17) 0.97

Dividend

Metric ADTX JAGX Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric ADTX JAGX Biotechnology median
Market cap 4.39m 4.18m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack